Kringle Pharma (TSE:4884) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4884 Kringle Pharma Inc TSE:4884
50 GF Score
Price 円362.00
GF Value 円483.87
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Kringle Pharma Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSE:4884
50GF Score
Kringle Pharma Inc TSE:4884
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kringle Pharma (TSE:4884) Overvalued in 2026?

Based on GuruFocus' analysis, Kringle Pharma stock appears to be undervalued. The current stock price of 円362.00 is trading 25.2% below its estimated GF Value™ of 円483.87. GuruFocus considers Kringle Pharma to be Modestly Undervalued.

Key valuation signals for TSE:4884:

  • Interest Received:
  • GF Value™: 円483.87 vs. price of 円362.00 (25.2% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the TSE:4884 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kringle Pharma Business Description

Address 7-7-15 Saito asagi, 207 Saito Bio-Incubator, Osaka Prefecture, Ibaraki, JPN, 567-0085
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases. The Company operates in a single segment, pharmaceutical development.
50GF Score

Get the complete analysis for TSE:4884

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円362.00
Price
円483.87
GF Value